Latent-transforming growth factor beta-binding protein 2 is a protein that in humans is encoded by the LTBP2gene.[1][2]
The protein encoded by this gene belongs to the family of latent transforming growth factor (TGF)-beta binding proteins (LTBP), which are extracellular matrix proteins with multi-domain structure. This protein is the largest member of the LTBP family possessing unique regions and with most similarity to the fibrillins. It has thus been suggested that it may have multiple functions: as a member of the TGF-beta latent complex, as a structural component of microfibrils, and a role in cell adhesion.[2]
References
↑Moren A, Olofsson A, Stenman G, Sahlin P, Kanzaki T, Claesson-Welsh L, ten Dijke P, Miyazono K, Heldin CH (Jan 1995). "Identification and characterization of LTBP-2, a novel latent transforming growth factor-beta-binding protein". J Biol Chem. 269 (51): 32469–78. PMID7798248.
Chambaz EM, Souchelnitskiy S, Pellerin S, et al. (1996). "Transforming growth factors-beta s: a multifunctional cytokine family. Implication in the regulation of adrenocortical cell endocrine functions". Horm. Res. 45 (3–5): 222–6. doi:10.1159/000184792. PMID8964588.
Munger JS, Harpel JG, Gleizes PE, et al. (1997). "Latent transforming growth factor-beta: structural features and mechanisms of activation". Kidney Int. 51 (5): 1376–82. doi:10.1038/ki.1997.188. PMID9150447.
Taipale J, Saharinen J, Keski-Oja J (1998). "Extracellular matrix-associated transforming growth factor-beta: role in cancer cell growth and invasion". Adv. Cancer Res. Advances in Cancer Research. 75: 87–134. doi:10.1016/S0065-230X(08)60740-X. ISBN978-0-12-006675-9. PMID9709808. |chapter= ignored (help)
Li X, Yin W, Pérez-Jurado L, et al. (1995). "Mapping of human and murine genes for latent TGF-beta binding protein-2 (LTBP2)". Mamm. Genome. 6 (1): 42–5. doi:10.1007/BF00350892. PMID7719025.
Bashir MM, Han MD, Abrams WR, et al. (1996). "Analysis of the human gene encoding latent transforming growth factor-beta-binding protein-2". Int. J. Biochem. Cell Biol. 28 (5): 531–42. doi:10.1016/1357-2725(95)00167-0. PMID8697098.
Hyytiäinen M, Taipale J, Heldin CH, Keski-Oja J (1998). "Recombinant latent transforming growth factor beta-binding protein 2 assembles to fibroblast extracellular matrix and is susceptible to proteolytic processing and release". J. Biol. Chem. 273 (32): 20669–76. doi:10.1074/jbc.273.32.20669. PMID9685426.
Wu X, Blanck A, Norstedt G, et al. (2002). "Identification of genes with higher expression in human uterine leiomyomas than in the corresponding myometrium". Mol. Hum. Reprod. 8 (3): 246–54. doi:10.1093/molehr/8.3.246. PMID11870232.
Heilig R, Eckenberg R, Petit JL, et al. (2003). "The DNA sequence and analysis of human chromosome 14". Nature. 421 (6923): 601–7. doi:10.1038/nature01348. PMID12508121.
Vehviläinen P, Hyytiäinen M, Keski-Oja J (2003). "Latent transforming growth factor-beta-binding protein 2 is an adhesion protein for melanoma cells". J. Biol. Chem. 278 (27): 24705–13. doi:10.1074/jbc.M212953200. PMID12716902.
Hirani R, Hanssen E, Gibson MA (2007). "LTBP-2 specifically interacts with the amino-terminal region of fibrillin-1 and competes with LTBP-1 for binding to this microfibrillar protein". Matrix Biol. 26 (4): 213–23. doi:10.1016/j.matbio.2006.12.006. PMID17293099.
